Stock HROW HARROW, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Harrow, Inc.

Equities

HROW

US4158581094

Real-time Estimate Cboe BZX
Other stock markets
 02:37:20 2024-05-28 pm EDT 		5-day change 1st Jan Change
18.2 USD +1.70% Intraday chart for Harrow, Inc. +10.61% +62.86%
May. 15 B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating MT
May. 14 Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours
Harrow, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Top Midday Decliners
Harrow, Inc. Provides Earnings Guidance for the Year 2024
Harrow, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Harrow, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Restore stock falls as weak tech trading drags down annual results
Harrow, Inc. Announces Board of Director Appointments
Harrow Health's Eye Treatment Drug Vevye Now Available in US
Harrow Announces Availability of Vevye® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
Harrow, Inc. Partners with Leading Healthcare Market Access Technology Platforms
Harrow Collaborating With Three Health Technology Platforms for US Launch of Vevye
Harrow, Inc. Appoints John P. Saharek as President and Chief Executive Officer of its ImprimisRx Division
Harrow, Inc. Completes Transfer of the TRIESENCE New Drug Application
Top Premarket Decliners
Harrow Health Q3 Core Loss Widens, Revenue Rises; Shares Plunge After Hours
Harrow, Inc. Revises Revenue Guidance for the Full Year 2023
Harrow, Inc. Provides Revenue Guidance for the First Quarter and Full Year 2024
Harrow, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Harrow, Inc. Announces Board and Committee Changes
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HROW Stock
  4. News Harrow, Inc.
  5. Other languages